Myrobalan Therapeutics Holding
Myrobalan Therapeutics Holding is a startup headquartered in Medford, United States, founded in 2023. It has raised at least $24.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Myrobalan Therapeutics Holding has raised at least $24.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Myrobalan Therapeutics Holding sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Medford
Related
- Innovation profile of Medford
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Myrobalan Therapeutics Holding do?
Myrobalan Therapeutics Holding is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Myrobalan Therapeutics Holding raised?
At least $24.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Myrobalan Therapeutics Holding based?
Myrobalan Therapeutics Holding is headquartered in Medford, United States.
When was Myrobalan Therapeutics Holding founded?
Myrobalan Therapeutics Holding was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.